Science Current Events | Science News | Brightsurf.com
 

Block its recycling system, and cancer kicks the can, according to new Penn study

May 09, 2012
Potent new drug kills tumor cells in mice by clogging up their recycling system

PHILADELPHIA - All cells have the ability to recycle unwanted or damaged proteins and reuse the building blocks as food. But cancer cells have ramped up the system, called autophagy, and rely on it to escape damage in the face of chemotherapy and other treatments. Now, researchers at the Perelman School of Medicine; the Abramson Cancer Center; and the School of Arts and Sciences, at the University of Pennsylvania, have developed a potent new drug that clogs up the recycling machinery and kills tumor cells in mouse models.

Ravi K. Amaravadi, MD, assistant professor of Medicine, and colleagues showed previously that an old malaria drug, hydroxychloroquine, reduces autophagy in cancer cells and makes them more likely to die when exposed to chemotherapy. The strategy is currently being tested in clinical trials, and preliminary results are promising. The catch, though, is that it's not always possible to give patients a high enough dose of hydroxychloroquine to have an effect on their tumor cells.

Amaravadi teamed up with Jeffrey Winkler, PhD, the Merriam Professor of Chemistry, to design a series of more potent versions of chloroquine. They describe the design, chemical synthesis, and biological evaluation of a highly effective, new compound called Lys05, in the early edition of the Proceedings of the National Academy of Sciences this week.

Unlike hydroxychloroquine, which has little impact on tumor cells when used as a single agent, the new drug, called Lys05, slows tumor growth in animal models even in the absence of other anti-tumor therapies. What's more, the Lys05 dose that is toxic to cancer cells, which are addicted to recycling and rely on it much more heavily than healthy cells, has little or no effect on healthy cells.

"We see that Lys05 has anti-tumor activity at doses that are non-toxic for the animals," Amaravadi says. "This single-agent anti-tumor activity suggests this drug, or its derivative, may be even more effective in patients than hydroxychloroquine." Remarkably, however, when the investigators increase the dose of Lys05, some animals develop symptoms that mimic a known genetic deficiency in an autophagy gene, ATG16L1, which affects some patients with Crohn's disease . That similarity - technically called a phenocopy - clearly shows that Lys05 works by interfering with the recycling system in cells.

Lys05, and its companion compound Lys01, aren't quite ready for testing in patients, according to Amaravadi. Before that can happen, the molecules need to be optimized and undergo more toxicity testing in animals. Amaravadi and Winkler hope to team up with an industry partner for that portion of the project.

In the meantime, though, Amaravadi says the work illustrates just how important autophagy is to cancer cells, and provides an important new step for future therapies.


University of Pennsylvania School of Medicine


Related Hydroxychloroquine Current Events and Hydroxychloroquine News Articles


In the quest for safer treatment for systemic lupus erythematosus
The treatment of systemic lupus erythematosus has traditionally been based on glucocorticoids administered orally.

Tamoxifen-resistant breast cancer reversed when drug paired with anti-malaria agent
The inexpensive anti-malarial drug hydroxychloroquine (HCQ) reverses resistance to tamoxifen, a widely used breast cancer drug, in mice.

Clinical trials designed to block autophagy in multiple cancers show promise
In the largest group of results to date, researchers from Penn Medicine's Abramson Cancer Center and other institutions have shown in clinical trials that the malaria drug hydroxychloroquine (HCQ) blocked autophagy in a host of aggressive cancers-glioblastoma, melanoma, lymphoma and myeloma, renal and colon cancers-and in some cases helped stabilize disease.

Long-term antibiotic treatment for Q fever causes weight gain
Scientists have unearthed still more evidence that antibiotics can contribute to obesity. Research published ahead of print in the journal Antimicrobial Agents and Chemotherapy suggests that patients on long-term antibiotic treatment gained weight and had significant changes in their gut microbiota.

Malaria drug combo could help prevent pregnancy complications in lupus patients
An anti-malaria drug combination might be useful in helping to prevent pregnancy complications in women with lupus and the related disorder antiphospholipid syndrome, Yale School of Medicine researchers have found in a new study published in the American Journal of Reproductive Immunology.

Mother's immunosuppressive medications not likely to put fetus at risk
Women with chronic autoimmune diseases who take immunosuppressive medications during their first trimester of pregnancy are not putting their babies at significantly increased risk of adverse outcomes, according to a Vanderbilt study released online by the journal Arthritis and Rheumatism.

US study shows that tofacitinib is an efficacious treatment for active RA
Results of a Phase III study presented today at the EULAR 2011 Annual Congress show that at 6 months, 58.3 percent of patients who had previously not responded to treatment with DMARDs, achieved ACR20 response (a 20 percent improvement in symptoms) when treated with the novel oral Janus kinase inhibitor tofacitinib at 10mg BID compared to 31.2 percent in the placebo group.

New approach to leukemia chemotherapy -- is a cure in sight?
Speaking at the UK National Stem Cell Network conference in York later today (31 March), Professor Tessa Holyoake from the University of Glasgow will discuss a brand new approach to treating chronic myeloid leukaemia (CML) in which a small number of cancer cells persist despite effective therapy thus preventing cure.

Malaria drug slows pancreatic cancer growth in mouse models
Dana-Farber Cancer Institute scientists report they have shrunk or slowed the growth of notoriously resistant pancreatic tumors in mice, using a drug routinely prescribed for malaria and rheumatoid arthritis.

Expression of certain transporter proteins may predict resistance to drug therapy
he expression of a transporter protein called the Breast Cancer Resistance Protein (BCRP) in rheumatoid arthritis (RA) patients may indicate higher disease activity and could be a barrier to the effectiveness of disease-modifying antirheumatic drugs (DMARDs), according to the results of a study presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy.
More Hydroxychloroquine Current Events and Hydroxychloroquine News Articles

Hydroxychloroquine and Chloroquine Retinopathy

Hydroxychloroquine and Chloroquine Retinopathy
by David J. Browning (Author)


Malpractice settlements are large for undetected hydroxychloroquine and chloroquine toxicity which, if untreated, can lead to permanent loss of central vision. Knowledge of the ocular toxicity of these drugs has increased during the past fifty years as their use has expanded. Hydroxychloroquine and Chloroquine Retinopathy is the first single-source book on the subject and is essential for the practicing ophthalmologists, rheumatologists, dermatologists, and internists who prescribe these drugs. It covers clinical topics such as signs and symptoms of toxicity, toxicity screening, ancillary testing, to whom and why the drugs are prescribed and dosing considerations. Additionally, the book addresses practice management considerations, including coding, reimbursement and equipment costs, and...

Hydroxychloroquine: Webster's Timeline History, 1956 - 2007

Hydroxychloroquine: Webster's Timeline History, 1956 - 2007
by Icon Group International (Author)


Webster's bibliographic and event-based timelines are comprehensive in scope, covering virtually all topics, geographic locations and people. They do so from a linguistic point of view, and in the case of this book, the focus is on "Hydroxychloroquine," including when used in literature (e.g. all authors that might have Hydroxychloroquine in their name). As such, this book represents the largest compilation of timeline events associated with Hydroxychloroquine when it is used in proper noun form. Webster's timelines cover bibliographic citations, patented inventions, as well as non-conventional and alternative meanings which capture ambiguities in usage. These furthermore cover all parts of speech (possessive, institutional usage, geographic usage) and contexts, including pop culture, the...

  Hydroxychloroquine retinopathy testing debated: data sparse.(Clinical Rounds): An article from: Internal Medicine News
by Robert Finn (Author)


This digital document is an article from Internal Medicine News, published by International Medical News Group on January 15, 2004. The length of the article is 702 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Hydroxychloroquine retinopathy testing debated: data sparse.(Clinical Rounds)
Author: Robert Finn
Publication: Internal Medicine News (Magazine/Journal)
Date: January 15, 2004
Publisher: International Medical News Group
Volume: 37 Issue: 2 Page: 22(1)

Distributed by Thomson...

  Hydroxychloroquine 'probably safe' in pregnancy.(Obstetrics): An article from: OB GYN News
by Jeff Evans (Author)


This digital document is an article from OB GYN News, published by International Medical News Group on February 1, 2005. The length of the article is 645 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Hydroxychloroquine 'probably safe' in pregnancy.(Obstetrics)
Author: Jeff Evans
Publication: OB GYN News (Magazine/Journal)
Date: February 1, 2005
Publisher: International Medical News Group
Volume: 40 Issue: 3 Page: 14(1)

Distributed by Thomson...

  Is hydroxychloroquine safe during pregnancy?(Rx): An article from: Internal Medicine News
by Jeff Evans (Author)


This digital document is an article from Internal Medicine News, published by International Medical News Group on February 15, 2005. The length of the article is 649 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Is hydroxychloroquine safe during pregnancy?(Rx)
Author: Jeff Evans
Publication: Internal Medicine News (Magazine/Journal)
Date: February 15, 2005
Publisher: International Medical News Group
Volume: 38 Issue: 4 Page: 51(1)

Distributed by Thomson...

  Hydroxychloroquine for arthritis also reduces risk of diabetes.(Across Specialties): An article from: Clinical Psychiatry News
by Mary Ann Moon (Author)


This digital document is an article from Clinical Psychiatry News, published by Thomson Gale on August 1, 2007. The length of the article is 487 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Hydroxychloroquine for arthritis also reduces risk of diabetes.(Across Specialties)
Author: Mary Ann Moon
Publication: Clinical Psychiatry News (Magazine/Journal)
Date: August 1, 2007
Publisher: Thomson Gale
Volume: 35 Issue: 8 Page: 55(1)

Distributed by Thomson...

Current Diagnosis & Treatment in Rheumatology, Third Edition (LANGE CURRENT Series)

Current Diagnosis & Treatment in Rheumatology, Third Edition (LANGE CURRENT Series)
by John Imboden (Author), David Hellmann (Author), John Stone (Author)


The most up-to-date and readily accessible rheumatology resource available The third edition of this trusted quick-reference guide has everything you need to keep pace with this fast-moving field—presented in the acclaimed CURRENT format. A practical reference for primary care providers, the book simplifies the treatment of difficult-to-manage rheumatologic diseases and disorders, such as arthritis, lupus, and sarcoidosis. Features NEW full-color photographs NEW chapters on clinical genetics, drug-induced syndromes, and metabolic myopathies Straightforward, expert coverage of the entire range of rheumatology disorders Full explanations of common and major disorders in clinical immunology Concise chapters geared to the needs of trainees and clinicians First section that...

The Lupus Encyclopedia: A Comprehensive Guide for Patients and Families (A Johns Hopkins Press Health Book)

The Lupus Encyclopedia: A Comprehensive Guide for Patients and Families (A Johns Hopkins Press Health Book)
by Donald E. Thomas Jr. MD FACP FACR (Author)


Systemic lupus erythematosus is an autoimmune disease that can affect any system and organ in the body. For the 1.4 million people in the United States who have lupus, an overactive immune system senses that different parts of the body do not belong, and it attacks these parts. The immune system may strike the cells that line the joints or tendons, for example, causing pain and swelling. An incredibly complex disease, lupus must be properly treated for the optimal health and well-being of the person who has it. The Lupus Encyclopedia is an authoritative compendium that provides detailed explanations of every body system potentially affected by the disease, along with practical advice about coping. People with lupus, their loved ones, caregivers, and medical professionals—all will find...

Handbook of Retinal OCT: Optical Coherence Tomography: Expert Consult: Online and Print, 1e

Handbook of Retinal OCT: Optical Coherence Tomography: Expert Consult: Online and Print, 1e
by Jay S. Duker MD (Author), Nadia K Waheed (Author), Darin Goldman (Author)


With Handbook of Retinal OCT, you can master the latest imaging methods used to evaluate retinal disease, uveitis, and optic nerve disorders. Ideal at any stage of your career, this easy-to-use, clinically oriented handbook provides a quick, templated, and portable guide for the interpretation of Optical Coherence Tomography scans. Locate answers quickly with templated chapters-each focused on one specific diagnosis or group of diagnoses with a particular OCT appearance. Adopt the latest techniques for evaluating age-related macular degeneration, diabetic retinopathy, retinal vein occlusion, and much more. See how the full spectrum of diseases presents through approximately 370 illustrations including the highest-quality spectral-domain OCT images available. Recognize image patterns...

A Body Out of Balance

A Body Out of Balance
by Nancy Carteron (Author), Ruth Fremes (Author)


One of the most common yet underrecognized autoimmune and rheumatological disorders.  Sjögren's (pronounced SHOW-grens) syndrome, or SjS, affects more people than rheumatoid arthritis and lupus combined.  Difficult to diagnose, SjS is characterized by symptoms that shift almost daily, usually beginning with vague discomforts such as dry eyes and dry mouth, then advancing to more severe concerns such as joint pain and swollen glands.  A Body Out of Balance provides a comprehensive guide to the wide array of symptoms, traditional and complementary treatments, and invaluable coping methods, so patients may devise a personal treatment plan.  Co written by a woman living with the disease and by a physician who has treated countless SjS patients, this indispensable resource will enhance...

© 2014 BrightSurf.com